Chapter·ManagementMI

Antiplatelet managementDownloads

10Questions
7Flashcards
3Tables & Flowcharts

Study Materials

Practice

Sample Questions

1

You are conducting a study comparing the efficacy of two different statin medications. Two groups are placed on different statin medications, statin A and statin B. Baseline LDL levels are drawn for each group and are subsequently measured every 3 months for 1 year. Average baseline LDL levels for each group were identical. The group receiving statin A exhibited an 11 mg/dL greater reduction in LDL in comparison to the statin B group. Your statistical analysis reports a p-value of 0.052. Which of the following best describes the meaning of this p-value?

AThere is a 95% chance that the difference in reduction of LDL observed reflects a real difference between the two groups

BThough A is more effective than B, there is a 5% chance the difference in reduction of LDL between the two groups is due to chance

CIf 100 permutations of this experiment were conducted, 5 of them would show similar results to those described above

DThis is a statistically significant result

EThere is a 5.2% chance of observing a difference in reduction of LDL of 11 mg/dL or greater even if the two medications have identical effects

2

A 66-year-old woman presents to the emergency department complaining of palpitations. She says that she has been experiencing palpitations and lightheadedness for the past 6 months, but before this morning the episodes usually resolved on their own. The patient's medical history is significant for a transient ischemia attack 2 months ago, hypertension, and diabetes. She takes aspirin, metformin, and lisinopril. She states her grandfather died of a stroke, and her mom has a "blood disorder." An electrocardiogram is obtained that shows an irregularly irregular rhythm with rapid ventricular response, consistent with atrial fibrillation. She is given intravenous metoprolol, which resolves her symptoms. In addition to starting a beta-blocker for long-term management, the patient meets criteria for anticoagulation. Both unfractionated heparin and warfarin are started. Five days later, the patient begins complaining of pain and swelling of her left lower extremity. A Doppler ultrasound reveals thrombosis in her left popliteal and tibial veins. A complete blood count is obtained that shows a decrease in platelet count from 245,000/mm^3 to 90,000/mm^3. Coagulation studies are shown below: Prothrombin time (PT): 15 seconds Partial thromboplastin time (PTT): 37 seconds Bleeding time: 14 minutes Which of the following is the most likely diagnosis?

AThrombotic thrombocytopenic purpura

BType I heparin-induced thrombocytopenia

CWarfarin toxicity

DIdiopathic thrombocytopenia purpura

EType II heparin-induced thrombocytopenia

3

A 54-year-old man comes to the physician for a follow-up examination. One week ago, he was treated in the emergency department for chest pain, palpitations, and dyspnea. As part of his regimen, he was started on a medication that irreversibly inhibits the synthesis of thromboxane A2 and prostaglandins. Which of the following is the most likely adverse effect of this medication?

ATinnitus

BGout attack

CChronic rhinosinusitis

DAcute interstitial nephritis

EGastrointestinal hemorrhage

+ 7 more in the PDF

More MI downloads

Browse all chapters

View all